Citadel Advisors’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,717
| Closed | -$17.1K | – | 7012 |
|
|
2023
Q3 | $17.1K | Buy |
+42,717
| New | +$17.1K | ﹤0.01% | 5339 |
|
|
2021
Q2 | – | Sell |
-20,000
| Closed | -$104K | – | 7564 |
|
|
2021
Q1 | $104K | Buy |
+20,000
| New | +$104K | ﹤0.01% | 5840 |
|
|
2019
Q4 | – | Sell |
-5,516
| Closed | -$40K | – | 5387 |
|
|
2019
Q3 | $40K | Buy |
5,516
+1,373
| +33% | +$9.96K | ﹤0.01% | 4398 |
|
|
2019
Q2 | $37K | Buy |
4,143
+522
| +14% | +$4.66K | ﹤0.01% | 4408 |
|
|
2019
Q1 | $35K | Buy |
+3,621
| New | +$35K | ﹤0.01% | 4323 |
|
|
2017
Q2 | – | Sell |
-1,193
| Closed | -$27K | – | 4396 |
|
|
2017
Q1 | $27K | Sell |
1,193
-682
| -36% | -$15.4K | ﹤0.01% | 3483 |
|
|
2016
Q4 | $15K | Buy |
1,875
+730
| +64% | +$5.84K | ﹤0.01% | 3491 |
|
|
2016
Q3 | $24K | Buy |
1,145
+339
| +42% | +$7.11K | ﹤0.01% | 3390 |
|
|
2016
Q2 | $21K | Buy |
+806
| New | +$21K | ﹤0.01% | 3182 |
|